References
Bourne, H.R. and Melmon, K.L.: Guides to the pharmacologic management of essential hypertension. Rational Drug Therapy 5: 1–4 (1971)
Brest, A.N.: Hypertension; in Conn (Ed) Current Therapy, p.201–206 (Saunders, Philadelphia 1974)
Clezy, T.M.: Oral contraceptives and hypertension: The effect of guanethidine. Medical Journal of Australia 57: 638–640 (1970)
Fann, W.E.: Interactions of psychotropic drugs in the elderly. Postgraduate Medicine 53: 182–186 (1973b)
Fann, W.E.: Some clinically important interactions of psychotropic drugs. Southern Medical Journal 66: 661–665 (1973a)
Fann, W.E.; Cavanaugh, J.H.; Kaufmann, J.S.; Griffith, J.D.; Davis, J.M.; Janowsky, D.S. and Oates, J.A.: Doxepin: Effects on transport of biogenic amines in man. Psychopharmacologia 22: 111–125 (1971)
Fann, W.E. and Wheless, J.C.: Depression in elderly patients. Southern Medical Journal 68: 468–473 (1975)
Flegin, O.T.; Morgan, D.H.; Oates, J.A. and Shand, D.G.: The mechanism of the reversal of the effect of guanethidine by amphetamines in cat and man. British Journal of Pharmacology 39: 253 (1970)
Fries, E.D.: The treatment of hypertension. American Journal of Medicine 52: 664–671 (1972)
Gant, B.R. and Waller, R.H.: Drug interaction index, p.39–40 (Meditec, Vancouver 1974)
Garb, S.: Undesirable drug interactions, p.200–202 (Springer, New York 1974)
Goldberg, L.I.: Current therapy of hypertension. American Journal of Medicine 58: 489–494 (1975)
Hansten, P.D.: Drug Interactions, 3rd ed, p.88–108 (Lea and Febiger, Philadelphia 1976)
Janowsky, D.S.; Khaled El-Yousef, M.; Davis, J.M. and Fann, W.E.: Chlorpromazine reversal of guanethidine hypotension. American Journal of Psychiatry 130: 808–812 (1973)
Janowsky, D.S.; Khaled El-Yousef, M.; Davis, J.M.; Fann, W.E. and Oates, J.A.: Guanethidine antagonism by antipsychotic drugs. Journal of the Tennessee Medical Association 65: 620–622 (1972)
Jefferson, J.W.G A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosomatic Medicine 37: 160–179 (1975)
Kaumann, A.; Basso, N. and Aramendia, P.: The cardiovascular effects of N(y-methyl-amino-propyl-iminodibenzyl) HCl (desmethylimipramine) and guanethidine. Journal of Pharmacology and Experimental Therapeutics 147: 54–64 (1965)
Koe, B.K. and Constantine, J.W.: Blocking 3H norepinephrine uptake and some guanethidine-induced effects with tricyclic anti-depressant drugs. Archives Internationales de Pharmacodynamie et de Therapie 195: 71–80 (1972)
Langford, H.G.: Hypertension; in Conn (Ed) Current Therapy, p.201–203 (Saunders, Philadelphia 1973)
Leishman, A.W.D.; Matthews, H.L. and Smith, A.J.: Antagonism of guanethidine by imipramine. Lancet 1: 112 (1963)
Martin, E.W.; Alexander, S.F.; Hassan, W.E.; Farage, D.J. and Martin, R.D.: Hazards of Medication, p.617–620 (Lippincott, Philadelphia 1971)
Misage, J.R. and McDonald, R.H.: Antagonism of the antihypertensive action of bethanidine by ‘common cold remedy’. British Medical Journal 4: 347 (1970)
Mitchell, J.R.; Arias, L. and Oates, J.A.: Antagonism of the anti-hypertensive action of guanethidine sulfate by desipramine hydrochloride. Journal of the American Medical Association 202: 973–976 (1967)
Mitchell, J.R.; Cavanaugh, J.H.; Arias, L. and Oates, J.A.: Guanethidine and related agents III. Antagonism by drugs which inhibit the norepinephrine pump in man. Journal of Clinical Investigation 49: 1596–1604 (1970)
Mitchell, J.R. and Oates, J.A.: Guanethidine and related agents I. Mechanisms of the selective blockade of adrenergic neurons and its antagonism by drugs. Journal of Pharmacology and Experimental Therapeutics 172: 100–107 (1970)
Morgan, D.H.; Oates, J.A. and Shand, D.G.: Evidence that guanethidine does not block adrenergic nerves by acting as a false transmitter. British Journal of Pharmacology 39: 186 (1970)
Morgan, J.P. and Bianchine, J.R.: The clinical pharmacology of levodopa. Rational Drug Therapy 5: 6 (1971)
Nies, A.S.: Adverse reactions and interactions limiting the use of antihypertensive drugs. American Journal of Medicine 58: 495–503 (1975)
Nithman, N.J.; Parkhurst, Y.E. and Sommers, E.B.: Physicians’ prescribing habits. Journal of the American Medical Association 217: 585–587 (1971)
Oates, J.A.: Seligmann, A.W.; Clark, M.A.; Rousseau, P. and Lee, R.E.: The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. New England Journal of Medicine 273: 729–734 (1965)
Ober, K.F. and Wang, R.I.H.: Drug interactions with guanethidine. Clinical Pharmacology and Therapeutics 14: 190–195 (1973)
Pickering, G.: High Blood Pressure, p.401–408 (Grune and Stratton, New York1968)
Sherman, A.P. and Walton, C.A.: Adrenergic transmission and drug interaction. Journal of the American Pharmaceutical Association 15: 86–90 (1975)
Simpson, F.O.: Hypertensive disease; In Avery (Ed) Drug Treatment, p.482 (ADIS Press, Sydney; Churchill Livingstone, Edinburgh, Publishing Sciences Group, Acton Mass. 1976)
Simpson, F.O. and Waal-Manning, H.J.: Hypertension and depression: Interrelated problems in therapy. Journal of the Royal College of Physicians of London 6: 14–24 (1971)
Stokes, G.S.: Drug-induced hypertension: Pathogenesis and management. Drugs 12: 222–230 (1976)
Stolley, P.D.; Becker, M.H.; Mcevilla, J.D.; Lasagna, L.; Gainor, M. and Sloane, L.M.: Drug prescribing and use in an American community. Annals of Internal Medicine 75: 537–540 (1972)
Stone, C.A.; Porter, C.C.; Stavorski, J.M.; Ludden, C.T. and Tofaro, J.A.: Antagonism of certain effects of catecholamine-depleting agents by antidepressant and related drugs. Journal of Pharmacology and Experimental Therapeutics 144: 196–204 (1964)
Talley, R. and Laventurier, M.: The incidence of drug-drug interactions in a medical population. Annals of Internal Medicine 76: 567 (1972)
Volle, R.L.: Introduction to the autonomic nervous system; in DiPalma (Ed) Drill’s Pharmacology in Medicine, p.506–509 (McGraw-Hill, New York 1971)
Williams, R.B. and Shelter, C.: Cardiac complications of tricyclic antidepressant therapy. Annals of Internal Medicine 74: 395–398 (1971)
Wilson, J.L.; Root, H.F. and Marble, A.: Diabetic nephropathy — a clinical syndrome. New England Journal of Medicine 245: 513–517 (1951)
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from the United States Veterans Administration.
Rights and permissions
About this article
Cite this article
Stafford, J.R., Fann, W.E. Drug Interactions with Guanidinium Antihypertensives. Drugs 13, 57–64 (1977). https://doi.org/10.2165/00003495-197713010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197713010-00007